Homestead Advisers Corp holds a diversified book of 111 stocks worth $3.7B as of Q1 2026 (disclosed May 8, 2026, a ~45-day 13F lag). This quarter they opened Motorola Solutions Inc and trimmed JPMorgan Chase & Co. Their largest long position is Exxon Mobil Corp at 4% of the equity book. Cloning the disclosed picks since 2016 would be +275% (+13.8%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/944804/holdings"
Use Arkolith to show HOMESTEAD ADVISERS CORP's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 32.8 points over this window.
Growth of $10,000 cloning Homestead Advisers Corp's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Exxon Mobil Corp COM | $162.6M | 957.1K | 4.4% | ▲+18% Added · +144K sh | |
| 2 | JPMorgan Chase & Co COM | $162.3M | 554.4K | 4.4% | ▼−1.1% Reduced · −6K sh | |
| 3 | Parker-Hannifin Corp COM | $126.4M | 141.9K | 3.4% | ▼−1.1% Reduced · −2K sh | |
| 4 | Alphabet Inc CAP STK CL C | $121.4M | 426.1K | 3.3% | ▼−1.1% Reduced · −5K sh | |
| 5 | Lam Research Corp COM NEW | $109.4M | 516.7K | 2.9% | ▼−28% Reduced · −200K sh | |
| 6 | Northrop Grumman Corp COM | $107.6M | 158.1K | 2.9% | ▼−1.0% Reduced · −2K sh | |
| 7 | Walmart Inc COM | $105.6M | 850.8K | 2.8% | ▼−1.1% Reduced · −10K sh | |
| 8 | Deere & Co COM | $105.4M | 187.4K | 2.8% | ▼−1.1% Reduced · −2K sh | |
| 9 | Abbvie Inc COM | $95.3M | 439.4K | 2.6% | ▼−17% Reduced · −91K sh | |
| 10 | Goldman Sachs Group Inc COM | $90.4M | 107.6K | 2.4% | ▼−36% Reduced · −60K sh | |
| 11 | Citigroup Inc COM NEW | $89.9M | 799.7K | 2.4% | ▼−8.4% Reduced · −74K sh | |
| 12 | Meta Platforms Inc CL A | $89.4M | 157.7K | 2.4% | ▼−1.1% Reduced · −2K sh | |
| 13 | Bank America Corp COM | $85.2M | 1.76M | 2.3% | ▲+14% Added · +210K sh | |
| 14 | ConocoPhillips COM | $84.1M | 636.5K | 2.3% | ▲+9.6% Added · +56K sh | |
| 15 | Honeywell Intl Inc COM | $81.6M | 361.5K | 2.2% | ▼−1.1% Reduced · −4K sh | |
| 16 | Eaton Corp PLC SHS | $81.0M | 227.8K | 2.2% | ▼−1.1% Reduced · −3K sh | |
| 17 | Boeing Co COM | $79.9M | 404.2K | 2.1% | ▼−1.1% Reduced · −5K sh | |
| 18 | Chubb Ltd Switz COM | $79.4M | 243.7K | 2.1% | ▼−9.7% Reduced · −26K sh | |
| 19 | Royalty Pharma PLC SHS CLASS A | $78.9M | 1.65M | 2.1% | ▼−1.1% Reduced · −19K sh | |
| 20 | Visa Inc COM CL A | $77.5M | 256.8K | 2.1% | ▼−1.1% Reduced · −3K sh | |
| 21 | TJX Cos Inc New COM | $77.0M | 483.6K | 2.1% | ▼−1.1% Reduced · −5K sh | |
| 22 | Freeport McMoran Inc CL B | $75.6M | 1.30M | 2.0% | ▼−1.1% Reduced · −15K sh | |
| 23 | Microsoft Corp COM | $74.6M | 202.5K | 2.0% | ▼−1.1% Reduced · −2K sh | |
| 24 | McDonalds Corp COM | $73.2M | 235.7K | 2.0% | ▼−6.1% Reduced · −15K sh | |
| 25 | Unitedhealth Group Inc COM | $71.2M | 264.5K | 1.9% | ▲+24% Added · +51K sh | |
| 26 | Disney Walt Co COM | $70.7M | 736.2K | 1.9% | ▼−1.1% Reduced · −8K sh | |
| 27 | Ameren Corp COM | $70.1M | 637.7K | 1.9% | ▼−1.1% Reduced · −7K sh | |
| 28 | Ge Healthcare Technologies I COMMON STOCK | $63.1M | 890.8K | 1.7% | ▼−1.1% Reduced · −10K sh | |
| 29 | Boston Scientific Corp COM | $59.1M | 942.1K | 1.6% | ▲+72% Added · +395K sh | |
| 30 | Allstate Corp COM | $54.7M | 263.6K | 1.5% | ▼−13% Reduced · −39K sh | |
| 31 | NXP Semiconductors N V COM | $54.4M | 278.0K | 1.5% | ▼−1.2% Reduced · −3K sh | |
| 32 | Caci Intl Inc CL A | $54.0M | 98.8K | 1.4% | ▼−1.0% Reduced · −1K sh | |
| 33 | Abbot Laboratories COM | $53.3M | 519.6K | 1.4% | ▼−34% Reduced · −267K sh | |
| 34 | CSX Corp COM | $53.0M | 1.30M | 1.4% | ▼−1.1% Reduced · −14K sh | |
| 35 | Avery Dennison Corp COM | $52.7M | 306.6K | 1.4% | ▼−1.1% Reduced · −3K sh | |
| 36 | Diamondback Energy Inc COM | $52.3M | 264.0K | 1.4% | ▲+48% Added · +86K sh | |
| 37 | Pulte Group Inc COM | $48.6M | 415.2K | 1.3% | ▼−1.1% Reduced · −5K sh | |
| 38 | The Cigna Group COM | $48.5M | 182.7K | 1.3% | ▼−1.2% Reduced · −2K sh | |
| 39 | Crown Castle Inc COM | $41.2M | 508.7K | 1.1% | ▼−1.1% Reduced · −6K sh | |
| 40 | Home Depot Inc COM | $40.7M | 124.2K | 1.1% | ▼−1.0% Reduced · −1K sh | |
| 41 | Motorola Solutions Inc COM NEW | $38.2M | 88.3K | 1.0% | ▲New New position | |
| 42 | Proctor & Gamble Co COM | $35.9M | 248.8K | 1.0% | ▼−1.1% Reduced · −3K sh | |
| 43 | Digital Rlty TR Inc COM | $34.1M | 190.2K | 0.9% | ▼−17% Reduced · −38K sh | |
| 44 | Truist Finl Corp COM | $33.1M | 722.2K | 0.9% | ▼−1.1% Reduced · −8K sh | |
| 45 | Dupont De Nemours Inc COM | $33.0M | 724.5K | 0.9% | ▼−1.1% Reduced · −8K sh | |
| 46 | Qnity Electronics Inc COMMON STOCK | $30.6M | 268.1K | 0.8% | ▼−27% Reduced · −98K sh | |
| 47 | Merck & Co Inc COM | $25.3M | 210.6K | 0.7% | ▼−1.0% Reduced · −2K sh | |
| 48 | T-Mobile US Inc COM | $24.8M | 117.7K | 0.7% | ▼−1.1% Reduced · −1K sh | |
| 49 | Transunion COM | $24.1M | 350.2K | 0.6% | ▼−1.1% Reduced · −4K sh | |
| 50 | Bristol-Myers Squibb Co COM | $22.4M | 370.0K | 0.6% | ▼−1.1% Reduced · −4K sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 8, 2026 | 111 | $3.7B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 10, 2026 | 107 | $3.8B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 5, 2025 | 104 | $4.2B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 | 101 | $4.2B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 | 98 | $4.1B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 12, 2025 | 102 | $4.1B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 1, 2024 | 98 | $4.2B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 23, 2024 | 98 | $4.1B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 10, 2024 | 133 | $4.3B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 13, 2024 | 134 | $3.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 | 131 | $3.6B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 25, 2023 | 129 | $3.8B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | Apr 27, 2023 | 134 | $3.6B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 3, 2023 | 130 | $3.7B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 7, 2022 | 135 | $3.3B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 1, 2022 | 132 | $3.5B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 | 135 | $4.1B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 7, 2022 | 137 | $4.3B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 5, 2021 | 139 | $4.1B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 2, 2021 | 140 | $4.3B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 7, 2021 | 109 | $4.2B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 10, 2021 | 104 | $4.0B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 100 | $3.7B | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 13, 2020 | 99 | $3.9B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.